The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...
6 天on MSN
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
A new non-opioid painkiller, suzetrigine, has just been approved by the US drug regulator, the FDA. It is the first ...
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than ...
Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.
6 天
HealthDay on MSNFDA Approves First New Non-Opioid Pain Pill in DecadesThe U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果